Header Logo

Haroun Rhemtula

Concepts (57)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pregnancy Complications, Cardiovascular
2
2021
30
0.900
 Why?
Hypertension, Pulmonary
1
2021
8
0.740
 Why?
Heart Defects, Congenital
1
2021
12
0.740
 Why?
Thrombosis
2
2023
47
0.400
 Why?
Venous Thromboembolism
2
2023
26
0.390
 Why?
Pregnancy
6
2023
1815
0.280
 Why?
Carcinoma, Neuroendocrine
2
2002
3
0.240
 Why?
Embolism
1
2023
4
0.210
 Why?
Uterine Cervical Neoplasms
2
2002
113
0.210
 Why?
Antiphospholipid Syndrome
1
2022
5
0.200
 Why?
Nervous System Malformations
1
2021
1
0.190
 Why?
Female
8
2023
8751
0.190
 Why?
Tertiary Care Centers
1
2021
78
0.180
 Why?
Pregnancy Outcome
1
2021
112
0.180
 Why?
Prothrombin
1
2019
8
0.170
 Why?
Pulmonary Embolism
1
2019
7
0.170
 Why?
Pregnancy Complications, Hematologic
1
2019
9
0.170
 Why?
Mutation
1
2019
299
0.150
 Why?
Humans
8
2023
14077
0.150
 Why?
Retrospective Studies
1
2021
767
0.150
 Why?
Anticoagulants
3
2023
51
0.140
 Why?
Infant, Newborn
1
2021
1410
0.140
 Why?
Infant
1
2021
2145
0.120
 Why?
South Africa
3
2023
7312
0.110
 Why?
Heparin, Low-Molecular-Weight
1
2023
10
0.050
 Why?
Enoxaparin
1
2023
11
0.050
 Why?
HIV Infections
1
2021
4946
0.050
 Why?
Hemorrhage
1
2023
70
0.050
 Why?
Pregnant Women
1
2023
89
0.050
 Why?
beta 2-Glycoprotein I
1
2022
4
0.050
 Why?
Lupus Coagulation Inhibitor
1
2022
4
0.050
 Why?
Antibodies, Antiphospholipid
1
2022
5
0.050
 Why?
Tumor Virus Infections
1
2002
3
0.050
 Why?
Antibodies, Anticardiolipin
1
2022
9
0.050
 Why?
Immunoglobulin M
1
2022
24
0.050
 Why?
Papillomaviridae
1
2002
33
0.050
 Why?
Synaptophysin
1
2001
3
0.050
 Why?
Longitudinal Studies
1
2023
409
0.050
 Why?
Fetus
1
2021
8
0.050
 Why?
Combined Modality Therapy
1
2001
25
0.050
 Why?
Immunohistochemistry
1
2001
26
0.050
 Why?
Warfarin
1
2021
15
0.050
 Why?
Biopsy
1
2001
37
0.050
 Why?
Parity
1
2001
19
0.050
 Why?
Neoplasm Staging
1
2001
48
0.050
 Why?
Papillomavirus Infections
1
2002
72
0.050
 Why?
Survival Analysis
1
2001
149
0.050
 Why?
Prognosis
1
2001
197
0.050
 Why?
Immunoglobulin G
1
2022
220
0.040
 Why?
Aged
2
2002
1650
0.040
 Why?
Case-Control Studies
1
2021
464
0.040
 Why?
Treatment Outcome
1
2001
867
0.040
 Why?
Middle Aged
2
2002
3425
0.030
 Why?
Risk Factors
1
2021
1431
0.030
 Why?
Adult
2
2019
5664
0.030
 Why?
In Situ Hybridization
1
2002
10
0.010
 Why?
Polymerase Chain Reaction
1
2002
260
0.010
 Why?
Rhemtula's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (57)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_